• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸芬氟拉明治疗德拉韦综合征的评价。

A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome.

机构信息

Department of Pediatrics and Pediatric Neurology, Antwerp University Hospital, Edegem, Belgium.

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

出版信息

Expert Rev Neurother. 2022 May;22(5):351-364. doi: 10.1080/14737175.2021.1877540. Epub 2021 Feb 26.

DOI:10.1080/14737175.2021.1877540
PMID:33455486
Abstract

INTRODUCTION

Dravet Syndrome (DS) is a severe developmental and epileptic encephalopathy. Fenfluramine recently demonstrated to be a highly efficacious and safe treatment option for DS patients. Fenfluramine has been recently approved by the FDA and EMA and is marketed as Fintepla®.

AREAS COVERED

DS and the need for additional anticonvulsive treatment options is discussed. The results of three placebo-controlled phase III studies (1 with and 2 without stiripentol) and 2 open label (extension) studies are reviewed. All studies demonstrate a consistent and impressive seizure reduction, confirming the results of two smaller investigator-initiated trials. The mechanism of action of fenfluramine is discussed. Finally, the place of fenfluramine in the future treatment of DS is outlined.

EXPERT OPINION

Fenfluramine has a potent anticonvulsive effect in DS. Although not yet fully elucidated, the anticonvulsive mechanism of fenfluramine seems to be mainly serotonergic. Fenfluramine is generally well tolerated. A dose reduction is necessary in combination with stiripentol. Considering new competitors, efficacy seems lower for cannabidiol and is comparable with stiripentol. Preclinical studies indicate a disease specific action and possible disease modification in DS. The latter would support the use of fenfluramine above its anticonvulsive effect and needs to be further elaborated.

摘要

简介

德拉维综合征(DS)是一种严重的发育性和癫痫性脑病。芬氟拉明最近被证明是 DS 患者的一种非常有效和安全的治疗选择。芬氟拉明最近已获得 FDA 和 EMA 的批准,并以 Fintepla®上市销售。

涵盖领域

DS 以及对额外抗惊厥治疗选择的需求进行了讨论。审查了三项安慰剂对照 III 期研究(1 项有和 2 项无司来吉兰)和 2 项开放标签(扩展)研究的结果。所有研究均表明一致且令人印象深刻的癫痫发作减少,证实了两项较小的研究者发起的试验的结果。讨论了芬氟拉明的作用机制。最后,概述了芬氟拉明在 DS 未来治疗中的地位。

专家意见

芬氟拉明对 DS 具有强大的抗惊厥作用。尽管尚未完全阐明,但芬氟拉明的抗惊厥机制似乎主要是血清素能的。芬氟拉明通常具有良好的耐受性。与司来吉兰合用需要减少剂量。考虑到新的竞争对手,大麻二酚的疗效似乎低于司来吉兰,与司来吉兰相当。临床前研究表明 DS 具有特定疾病的作用和可能的疾病修饰。后者将支持将芬氟拉明用于其抗惊厥作用之上,需要进一步阐述。

相似文献

1
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome.盐酸芬氟拉明治疗德拉韦综合征的评价。
Expert Rev Neurother. 2022 May;22(5):351-364. doi: 10.1080/14737175.2021.1877540. Epub 2021 Feb 26.
2
Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison.添加抗癫痫药物治疗Dravet综合征的短期疗效和安全性比较:间接治疗比较
Seizure. 2021 Oct;91:316-324. doi: 10.1016/j.seizure.2021.06.020. Epub 2021 Jun 29.
3
Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.Dravet 综合征的药物治疗:随机对照试验的系统评价和网络荟萃分析。
Drugs. 2023 Oct;83(15):1409-1424. doi: 10.1007/s40265-023-01936-y. Epub 2023 Sep 11.
4
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.多准则决策分析在西班牙用芬氟拉明治疗德拉韦综合征中的贡献。
Epilepsy Behav. 2022 Jul;132:108711. doi: 10.1016/j.yebeh.2022.108711. Epub 2022 May 16.
5
Stiripentol for the treatment of seizures associated with Dravet syndrome.司替戊醇治疗 Dravet 综合征相关癫痫发作。
Expert Rev Neurother. 2019 Apr;19(4):301-310. doi: 10.1080/14737175.2019.1593142. Epub 2019 Apr 2.
6
Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis.比较屈昔多巴、大麻二酚和芬氟拉明作为 Dravet 综合征癫痫发作一线附加治疗的疗效和安全性:一项网络荟萃分析。
Epilepsia Open. 2024 Apr;9(2):689-703. doi: 10.1002/epi4.12923. Epub 2024 Mar 1.
7
Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.治疗抵抗性 Dravet 综合征:新型药物的考虑因素。
J Pediatr Health Care. 2022 Sep-Oct;36(5):479-488. doi: 10.1016/j.pedhc.2022.05.003.
8
Therapeutic advances in Dravet syndrome: a targeted literature review.德雷维特综合征的治疗进展:一项针对性文献综述。
Expert Rev Neurother. 2020 Oct;20(10):1065-1079. doi: 10.1080/14737175.2020.1801423. Epub 2020 Aug 16.
9
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.芬氟拉明治疗伴有 stiripentol 的治疗抵抗性癫痫发作的杜氏肌营养不良症患者:一项随机临床试验。
JAMA Neurol. 2020 Mar 1;77(3):300-308. doi: 10.1001/jamaneurol.2019.4113.
10
Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.低剂量芬氟拉明显著降低德雷维特综合征的癫痫发作频率:一项对新患者队列的前瞻性研究。
Eur J Neurol. 2017 Feb;24(2):309-314. doi: 10.1111/ene.13195. Epub 2016 Oct 28.

引用本文的文献

1
Pathophysiology to Risk Factor and Therapeutics to Treatment Strategies on Epilepsy.癫痫的病理生理学、风险因素、治疗方法及治疗策略
Brain Sci. 2024 Jan 10;14(1):71. doi: 10.3390/brainsci14010071.
2
Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy.德拉维特综合征的临床和遗传特征:精准医学在遗传性癫痫中的作用的典型范例。
Int J Mol Sci. 2023 Dec 19;25(1):31. doi: 10.3390/ijms25010031.
3
Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes.芬氟拉明:用于德拉维特综合征和 Lennox-Gastaut 综合征的评价。
Drugs. 2023 Jul;83(10):923-934. doi: 10.1007/s40265-023-01881-w. Epub 2023 Jun 15.
4
Fenfluramine: a plethora of mechanisms?芬氟拉明:众多机制?
Front Pharmacol. 2023 May 12;14:1192022. doi: 10.3389/fphar.2023.1192022. eCollection 2023.
5
Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons from Dravet Syndrome.靶向分子策略治疗遗传性神经发育障碍:德拉维特综合征的新启示。
Neuroscientist. 2023 Dec;29(6):732-750. doi: 10.1177/10738584221088244. Epub 2022 Apr 13.
6
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.抗癫痫药物治疗 Dravet 综合征实用指南。
CNS Drugs. 2022 Mar;36(3):217-237. doi: 10.1007/s40263-022-00898-1. Epub 2022 Feb 14.
7
Serotonin receptors in epilepsy: Novel treatment targets?癫痫中的血清素受体:新的治疗靶点?
Epilepsia Open. 2022 Jun;7(2):231-246. doi: 10.1002/epi4.12580. Epub 2022 Feb 2.
8
Use of Zebrafish Models to Boost Research in Rare Genetic Diseases.利用斑马鱼模型促进罕见遗传疾病研究。
Int J Mol Sci. 2021 Dec 12;22(24):13356. doi: 10.3390/ijms222413356.